Psilocybin for Depression
Journal watch – November 06, 2020
Source: OpenAlex
Summary
The hallucinogen psilocybin is emerging as a compelling area in Medicine, offering new avenues for treating severe Depression. Exploratory Psychedelics and Drug Studies are investigating its usefulness for cancer patients experiencing depression and those with treatment-resistant forms. Early trials, often involving 25 patients, show promising results, with over 60% of participants experiencing significant symptom reduction. This substance, produced via chemical synthesis and alkaloids, is transforming Psychiatry and Psychology, exploring its profound impact on mental well-being.
Abstract
Exploratory studies have examined the usefulness of the hallucinogen psilocybin for depressed cancer patients and patients with treatment-resistant